tirzepatide surmount 1 Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials | Advances in Therapy SURMOUNT-1: Tirzepatide Provides Significant, Sustained

They are mainly prescribed to lower blood glucose levels and reduce weight

The SURMOUNT-4 trial (Aronne 2023, JAMA) showed that adults who stopped tirzepatide after 36 weeks regained an average of 14.0% of body weight over the next 52 weeks, while those who continued tirzepatide lost an additional 5.5% a 19.4% between-group difference

You should consult with your doctor before starting any new medication or weight loss program to make sure it is safe and appropriate for you

Refreshing and Non-drying: The dense foam soft the cuticle of the face, and with the fresh scent, it keeps you refreshed all day long, face skin wont be tight after cleansing